Spyre Therapeutics (SYRE) Q1 2025 Earnings

Feb 27Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.36
-1.18
-0.99
-0.81

Details

Expected EPS
-0.986136
Actual EPS
-0.81
Surprise EPS
0.18
Surprise Percent
+17.86%

Description

⁨Spyre Therapeutics⁩ (⁦SYRE⁩) has reported earnings of ⁦-0.81⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts